EUVIMEDEUVIMED entdecken
Open Access

Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Sclerosis

Vera Taluntiene, Natasa Giedraitiene, Rasa Kizlaitiene, Mantas Vaisvilas, Gintaras Kaubrys iD

Medical Science Monitor · 2025

DOI: 10.12659/msm.948757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Vera Taluntiene und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Multiple Sclerosis, Disability Evaluation, Neurofilament Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND This study investigated whether cerebrospinal fluid (CSF) and serum neurofilament light chain (NfL), a biomarker of axonal degeneration, combined with manual dexterity and ambulation measures, can serve as reliable predictors of MS-related cognitive impairment (CI). MATERIAL AND METHODS A total of 99 newly diagnosed patients with MS (PwMS) and 37 healthy controls (control group [CG]) were included in the study. Serum NfL levels were measured in both groups, whereas PwMS also underwent CSF NfL analysis. Cognition was assessed using the Brief International Cognitive Assessment for MS (BICAMS) test battery. Disability was evaluated using the Expanded Disability Status Scale (EDSS), Nine-Hole Peg Test (NHPT), and Timed 25-Foot Walk Test (T25FWT). PwMS were classified as cognitively impaired if Z-scores of 1 or more BICAMS tests were below -1.5 standard deviations from the mean of the CG scores. RESULTS PwMS had significantly lower median scores in the Brief Visuospatial Memory and Learning Revised (BVMT-R) and California Verbal Learning Test II (CVLT) (p=0.003 and p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionMultiple SclerosisDisability EvaluationNeurofilament ProteinsRisk AssessmentWalk TestBiomarkersCase-Control StudiesNeuropsychological TestsProspective StudiesHumansMaleFemaleAdolescentYoung AdultAdultMiddle Aged

Substanzen

neurofilament protein LNeurofilament ProteinsBiomarkers

Autor:innen und Institutionen

  • Clinic of Neurology and Neurosurgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

ORCID-Profile: Gintaras Kaubrys

Zitieren

APA

Taluntiene, V., Giedraitiene, N., Kizlaitiene, R., Vaisvilas, M., & Kaubrys, G. (2025). Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Sclerosis. Medical Science Monitor. https://doi.org/10.12659/msm.948757

Vancouver

Taluntiene V, Giedraitiene N, Kizlaitiene R, Vaisvilas M, Kaubrys G. Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Sclerosis. Medical Science Monitor. 2025. doi:10.12659/msm.948757

BibTeX
@article{Taluntiene2025,
  author = {Taluntiene, Vera and Giedraitiene, Natasa and Kizlaitiene, Rasa and Vaisvilas, Mantas and Kaubrys, Gintaras},
  title = {Neurofilament Light Chain and Disability Measures as Predictors of Cognitive Decline in Early Multiple Sclerosis},
  journal = {Medical Science Monitor},
  year = {2025},
  doi = {10.12659/msm.948757}
}
Kostenlos starten →